This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.

Ok, Got It

Sue MacLeman

Non-Executive Director

Sue MacLeman

Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development.

Sue has served as CEO and Board member of several ASX and NASDAQ listed companies in the healthtech sector. She is current Chair of MTPConnect, a not-for-profit industry growth centre for the medtech, biotech and pharmaceutical sectors. She is also Chair of Oventus Medical Ltd (ASX:OVN) and TALi Digital Ltd (ASX:TDI), and a non-executive director of Anatara Lifesciences Ltd (ASX:ANR), Palla Pharma Ltd (ASX:PAL) and Omico.

Sue is appointed to several academic and government advisory boards including the Prime Minister’s Digital Expert Advisory Board, CSIRO Health and Biosecurity Advisory Committee, DMTC Medical Countermeasures, Genomics Health Futures Expert Advisory Committee (MRFF) and a number of COVID-19 taskforces.

Her broad commercial and technical experience is underpinned by a Bachelor of Pharmacy from the University of Queensland, a Master of Laws from Deakin University and a Master of Marketing from Melbourne Business School. She ­is also a Fellow and Chair of the Health Forum at the Australian Academy of Technology and Engineering (ATSE) and Fellow/Graduate of Australian Institute of Company Directors (AICD).